Titan Medical to raise $21 mln in equity from Shanghai Jugu

Titan Medical Inc (TSX: TMD), a Canadian robotic surgical technology company, has agreed to receive about $21 million (US$16 million) from Shanghai Jugu Equity Investment Fund, a Chinese private equity and venture capital firm. The investment, which will made in two tranches, will support Titan in the on-going development and commercialization of its SPORT system, a surgeon-controlled robotic platform designed for use in minimally invasive surgery. The Toronto-based company plans to introduce the system to markets in Europe and the United States over 2016-2017.

1 June 2016•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail